About the Cancer and Metabolic Disorders Session
The relationship between cancer and metabolic disorders is a growing area of research. Many cancer patients experience disruptions in metabolic pathways that can affect overall health and treatment outcomes. Conditions such as obesity, diabetes, and metabolic syndrome have been shown to increase the risk of developing certain cancers and complicate cancer treatment. Cancer research is focused on understanding the metabolic changes that occur in cancer cells, such as altered glucose and lipid metabolism, and how these affect tumor progression. Researchers are also investigating metabolic therapies that could disrupt these processes to slow down or stop cancer growth, providing a new avenue for treatment in conjunction with traditional therapies.
Topics Covered in Cancer and Metabolic Disorders
Obesity-Related Cancers
Diabetes & Hyperinsulinemia
Metabolic Syndrome
Adipokine Signaling
Altered Lipid Metabolism
Metabolic Drug Repurposing
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer and Metabolic Disorders Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer and Metabolic Disorders work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer and Metabolic Disorders research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer and Metabolic Disorders track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer and Metabolic Disorders Conference 2027 — FAQs
What is the Cancer and Metabolic Disorders track at CIOC 2027?
The Cancer and Metabolic Disorders track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer and Metabolic Disorders. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer and Metabolic Disorders sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer and Metabolic Disorders are all welcome — whether presenting or attending.
Can I present my research in the Cancer and Metabolic Disorders track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer and Metabolic Disorders sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer and Metabolic Disorders track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.